{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T14:43:36Z","timestamp":1765464216156,"version":"3.48.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["No. 2023-I2M-2-006"],"award-info":[{"award-number":["No. 2023-I2M-2-006"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s11095-025-03955-8","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:26:55Z","timestamp":1761582415000},"page":"1981-1992","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Profiling Interactions Between Bicyclol and SLC\/ABC Transporters: Advancing Clinical Safety and Efficacy in Combination Therapy"],"prefix":"10.1007","volume":"42","author":[{"given":"Wanting","family":"Bai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinjin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"issue":"12","key":"3955_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-039700","volume":"10","author":"H Li","year":"2020","unstructured":"Li H, Liu NN, Peng ZG. Effect of bicyclol on blood biomarkers of NAFLD: a systematic review and meta-analysis. BMJ Open. 2020;10(12):e039700.","journal-title":"BMJ Open"},{"issue":"8","key":"3955_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1080\/00498254.2018.1524186","volume":"49","author":"S Yang","year":"2019","unstructured":"Yang S, Hu J, Li Y, Zhao Z. Evaluation of pharmacokinetic interactions between bicyclol and co-administered drugs in rat and human liver microsomes in vitro and in rats in vivo. Xenobiotica. 2019;49(8):987\u201394.","journal-title":"Xenobiotica"},{"key":"3955_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105518","volume":"154","author":"M Hu","year":"2020","unstructured":"Hu M, Li Y, You F, Bai J, Fan X, Zhao S, et al. Comparison and identification of metabolic profiling of bicyclol in rats, dogs and humans in vitro and in vivo. Eur J Pharm Sci. 2020;154:105518.","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"3955_CR4","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1080\/17425255.2021.1915284","volume":"17","author":"H Koepsell","year":"2021","unstructured":"Koepsell H. Update on drug-drug interaction at organic cation transporters: mechanisms, clinical impact, and proposal for advanced in vitro testing. Expert Opin Drug Metab Toxicol. 2021;17(6):635\u201353.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"6","key":"3955_CR5","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1158\/1078-0432.CCR-12-3306","volume":"19","author":"EI Zimmerman","year":"2013","unstructured":"Zimmerman EI, Hu S, Roberts JL, Gibson AA, Orwick SJ, Li L, et al. Contribution of OATP1B1 and OATP1B3 to the disposition of sorafenib and sorafenib-glucuronide. Clin Cancer Res. 2013;19(6):1458\u201366.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"3955_CR6","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1124\/jpet.110.169433","volume":"334","author":"S Watanabe","year":"2010","unstructured":"Watanabe S, Tsuda M, Terada T, Katsura T, Inui K. Reduced renal clearance of a zwitterionic substrate cephalexin in MATE1-deficient mice. J Pharmacol Exp Ther. 2010;334(2):651\u20136.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"3955_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0214862","volume":"14","author":"K Nishizawa","year":"2019","unstructured":"Nishizawa K, Yoda N, Morokado F, Komori H, Nakanishi T, Tamai I. Changes of drug pharmacokinetics mediated by downregulation of kidney organic cation transporters Mate1 and Oct2 in a rat model of hyperuricemia. PLoS ONE. 2019;14(4):e0214862.","journal-title":"PLoS ONE"},{"key":"3955_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-1-4939-0956-8_6","volume":"1175","author":"TM Sissung","year":"2014","unstructured":"Sissung TM, Goey AK, Ley AM, Strope JD, Figg WD. Pharmacogenetics of membrane transporters: a review of current approaches. Methods Mol Biol. 2014;1175:91\u2013120.","journal-title":"Methods Mol Biol"},{"issue":"6","key":"3955_CR9","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1248\/bpb.b16-00970","volume":"40","author":"M Iwaki","year":"2017","unstructured":"Iwaki M, Shimada H, Irino Y, Take M, Egashira S. Inhibition of methotrexate uptake via organic anion transporters OAT1 and OAT3 by glucuronides of nonsteroidal anti-inflammatory drugs. Biol Pharm Bull. 2017;40(6):926\u201331.","journal-title":"Biol Pharm Bull"},{"key":"3955_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2019.105153","volume":"142","author":"W Shu","year":"2020","unstructured":"Shu W, Ma L, Hu X, Zhang M, Chen W, Ma W, et al. Drug-drug interaction between crizotinib and entecavir via renal secretory transporter OCT2. Eur J Pharm Sci. 2020;142:105153.","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"3955_CR11","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1002\/cpt.2369","volume":"110","author":"N Gronich","year":"2021","unstructured":"Gronich N, Stein N, Muszkat M. Association between use of pharmacokinetic-interacting drugs and effectiveness and safety of direct acting oral anticoagulants: nested case-control study. Clin Pharmacol Ther. 2021;110(6):1526\u201336.","journal-title":"Clin Pharmacol Ther"},{"key":"3955_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.medidd.2021.100096","volume":"11","author":"S Fu","year":"2021","unstructured":"Fu S, Yu F, Sun T, Hu Z. Transporter-mediated drug\u2013drug interactions \u2013 Study design, data analysis, and implications for in vitro evaluations. Med Drug Discov. 2021;11:100096.","journal-title":"Med Drug Discov"},{"issue":"6","key":"3955_CR13","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.clinthera.2024.04.008","volume":"46","author":"J Yu","year":"2024","unstructured":"Yu J, Wang Y, Ragueneau-Majlessi I. Risk of enzyme- and transporter-mediated drug interactions with drugs approved by the US food and drug administration in 2022: a detailed analysis of in vitro and clinical data available in new drug application reviews. Clin Ther. 2024;46(6):499\u2013508.","journal-title":"Clin Ther"},{"key":"3955_CR14","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ejps.2015.06.020","volume":"77","author":"B Wang","year":"2015","unstructured":"Wang B, Liu Z, Li D, Yang S, Hu J, Chen H, et al. Application of physiologically based pharmacokinetic modeling in the prediction of pharmacokinetics of bicyclol controlled-release formulation in human. Eur J Pharm Sci. 2015;77:265\u201372.","journal-title":"Eur J Pharm Sci"},{"key":"3955_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1146\/annurev-pharmtox-010611-134529","volume":"52","author":"MK DeGorter","year":"2012","unstructured":"DeGorter MK, Xia CQ, Yang JJ, Kim RB. Drug transporters in drug efficacy and toxicity. Annu Rev Pharmacol Toxicol. 2012;52:249\u201373.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"07","key":"3955_CR16","first-page":"30","volume":"39","author":"Y Gu","year":"2010","unstructured":"Gu Y, Wang B, Li Y. Mutual influence on plasma pharmacokinetics after repeated oral administration of Bicyclol and Lamivudine in rats. J Med Res. 2010;39(07):30\u20133.","journal-title":"J Med Res"},{"issue":"17","key":"3955_CR17","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1111\/bph.14393","volume":"175","author":"J Dong","year":"2018","unstructured":"Dong J, Olaleye OE, Jiang R, Li J, Lu C, Du F, et al. Glycyrrhizin has a high likelihood to be a victim of drug-drug interactions mediated by hepatic organic anion-transporting polypeptide 1B1\/1B3. Br J Pharmacol. 2018;175(17):3486\u2013503.","journal-title":"Br J Pharmacol"},{"key":"3955_CR18","doi-asserted-by":"crossref","unstructured":"Van Rossum T, De Man R. glycyrrhizin as a potential treatment for chronic hepatitis C. Alimentary pharmacology & therapeutics. 1998;12(3).","DOI":"10.1046\/j.1365-2036.1998.00309.x"},{"issue":"4","key":"3955_CR19","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1080\/00498254.2016.1187777","volume":"47","author":"FT Hagos","year":"2017","unstructured":"Hagos FT, Daood MJ, Ocque JA, Nolin TD, Bayir H, Poloyac SM, et al. Probenecid, an organic anion transporter 1 and 3 inhibitor, increases plasma and brain exposure of N-acetylcysteine. Xenobiotica. 2017;47(4):346\u201353.","journal-title":"Xenobiotica"},{"issue":"4","key":"3955_CR20","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1046\/j.1365-2036.1997.00209.x","volume":"11","author":"AL Jones","year":"1997","unstructured":"Jones AL, Jarvie DR, Simpson D, Hayes PC, Prescott LF. Pharmacokinetics of N-acetylcysteine are altered in patients with chronic liver disease. Aliment Pharmacol Ther. 1997;11(4):787\u201391.","journal-title":"Aliment Pharmacol Ther"},{"issue":"03","key":"3955_CR21","first-page":"85","volume":"20","author":"W Zuo","year":"2022","unstructured":"Zuo W, Gao D-h, Hu Y, Han B, Zhang B. Eltrombopag-induced hyperpigmentation in an idiopathic thrombocytopenic purpura patient: a case report. Clinical Medication Journal. 2022;20(03):85\u20138.","journal-title":"Clinical Medication Journal"},{"key":"3955_CR22","unstructured":"Sun Y. Clinical and Experimental Study on the Protective Effect of Bicyclol Tablets Against Drug-Induced Liver Injury in the Treatment of Severe Psoriasis. In.; 2013."},{"issue":"9","key":"3955_CR23","first-page":"1746","volume":"40","author":"Hepatology Group CDMB, China Medicinal Biotechnology Association","year":"2024","unstructured":"Hepatology Group CDMB, China Medicinal Biotechnology Association. Multidisciplinary expert consensus on bicyclol in prevention and treatment of inflammatory liver injury. J Clin Hepatol. 2024;40(9):1746.","journal-title":"J Clin Hepatol"},{"issue":"5","key":"3955_CR24","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/sj.bjc.6604213","volume":"98","author":"C Lemos","year":"2008","unstructured":"Lemos C, Jansen G, Peters GJ. Drug transporters: recent advances concerning BCRP and tyrosine kinase inhibitors. Br J Cancer. 2008;98(5):857\u201362.","journal-title":"Br J Cancer"},{"key":"3955_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15112535","author":"NE Verhagen","year":"2023","unstructured":"Verhagen NE, Koenderink JB, Blijlevens NMA, Janssen J, Russel FGM. Transporter-mediated cellular distribution of tyrosine kinase inhibitors as a potential resistance mechanism in chronic myeloid leukemia. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15112535.","journal-title":"Pharmaceutics"},{"issue":"6","key":"3955_CR26","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.trsl.2013.08.003","volume":"162","author":"AAK El-Sheikh","year":"2013","unstructured":"El-Sheikh AAK, Greupink R, Wortelboer HM, van den Heuvel JJMW, Schreurs M, Koenderink JB, et al. Interaction of immunosuppressive drugs with human organic anion transporter (OAT) 1 and OAT3, and multidrug resistance-associated protein (MRP) 2 and MRP4. Transl Res. 2013;162(6):398\u2013409.","journal-title":"Transl Res"},{"key":"3955_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01438","volume":"9","author":"H Li","year":"2018","unstructured":"Li H, Li JR, Huang MH, Chen JH, Lv XQ, Zou LL, et al. Bicyclol attenuates liver inflammation induced by infection of Hepatitis C virus via repressing ROS-mediated activation of MAPK\/NF-\u03baB signaling pathway. Front Pharmacol. 2018;9:1438.","journal-title":"Front Pharmacol"},{"issue":"11","key":"3955_CR28","first-page":"968","volume":"21","author":"Y Wang","year":"2016","unstructured":"Wang Y, Hu J. Effect of bicyclol on the plasma pharmacokinetics of tacrolimus and atorvastatin after oral administration in rats. Chin Hepatol. 2016;21(11):968\u201371.","journal-title":"Chin Hepatol"},{"issue":"01","key":"3955_CR29","first-page":"99","volume":"35","author":"F Feng","year":"2013","unstructured":"Feng F. Clinical observation on the efficacy of Bicyclol combined with Metformin and Atorvastatin in the treatment of non-alcoholic fatty liver disease. Fujian Med J. 2013;35(01):99\u2013101.","journal-title":"Fujian Med J"},{"issue":"06","key":"3955_CR30","first-page":"216","volume":"17","author":"J Wang","year":"2015","unstructured":"Wang J. Clinical study on the prevention and treatment of liver injury with Bicyclol tablets during chemotherapy for advanced non-small cell lung cancer. Journal of North China Coal Medical College. 2015;17(06):216\u20138.","journal-title":"Journal of North China Coal Medical College"},{"issue":"12","key":"3955_CR31","first-page":"50","volume":"14","author":"H Liu","year":"2015","unstructured":"Liu H. Clinical Study on Bicyclol Tablets in the Prevention and Treatment of Liver Injury During Chemotherapy for Advanced Non-Small Cell Lung Cancer. Health Way. 2015;14(12):50.","journal-title":"Health Way"},{"key":"3955_CR32","unstructured":"Li B. Study on the Effect of Schisandra Preparations on Tacrolimus Blood Concentration and Their Protective Effect Against Liver Injury. In.; 2013."},{"issue":"6","key":"3955_CR33","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/S0016-5085(76)80326-5","volume":"70","author":"MJ Koch","year":"1976","unstructured":"Koch MJ, Seeff LB, Crumley CE, Rabin L, Burns WA. Quinidine, hepatotoxicity: a report of a case and review of the literature. Gastroenterology. 1976;70(6):1136\u201340.","journal-title":"Gastroenterology"},{"issue":"01","key":"3955_CR34","first-page":"101","volume":"5","author":"K Wang","year":"2011","unstructured":"Wang K, Qu Q, Miao S. Clinical observation on the efficacy of Bicyclol in the prevention and treatment of drug-induced liver injury after kidney transplantation. Chin J Mod Drug Appl. 2011;5(01):101\u20132.","journal-title":"Chin J Mod Drug Appl"},{"issue":"10","key":"3955_CR35","first-page":"798","volume":"20","author":"J Zhao","year":"2015","unstructured":"Zhao J, Peng G, Xie R. Clinical observation on the efficacy of bicyclol tablets in treating antiretroviral therapy-associated drug-induced liver injury in chronic HIV-infected patients. Chin Hepatol. 2015;20(10):798\u2013802.","journal-title":"Chin Hepatol"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-025-03955-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-025-03955-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-025-03955-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T14:35:13Z","timestamp":1765463713000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-025-03955-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["3955"],"URL":"https:\/\/doi.org\/10.1007\/s11095-025-03955-8","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"type":"print","value":"0724-8741"},{"type":"electronic","value":"1573-904X"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article has been updated to fix the affiliation tagging in the authorlist for authors Wanting Bail, Yang Li, Feng You and Pei Lan.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}